Circulating microparticles, protein C, free protein S and endothelial vascular markers in children with sickle cell anaemia-Reference-Cited by-同舟云学术

Circulating microparticles, protein C, free protein S and endothelial vascular markers in children with sickle cell anaemia

Published:2015-01-01 Issue:1 Volume:4 Page:28414
ISSN:2001-3078
Container-title:Journal of Extracellular Vesicles
language:en
Short-container-title:Journal of Extracellular Vesicles

Author:

Piccin Andrea¹²³⁴,Murphy Ciaran¹,Eakins Elva¹,Kunde Jan⁵,Corvetta Daisy⁴⁶,Di Pierro Angela⁴,Negri Giovanni⁶,Guido Mazzoleni⁶,Sainati Laura⁷,Mc Mahon Corrina²,Smith Owen Patrick²³,Murphy William¹⁸

Affiliation:

1. Irish Blood Transfusion Service Dublin, Ireland

2. Our Lady's Children Hospital, Dublin, Ireland

3. Department of Haematology Trinity College Dublin, Dublin Ireland

4. Haematology Department San Maurizio Regional Hospital, Bolzano, Italy

5. B.R.A.H.M.S. AG Biotechnology Centre, Berlin, Germany

6. Pathology Department San Maurizio Regional Hospital, Bolzano, Italy

7. Clinica di Oncoematologia Pediatrica, Azienda Ospedaliera, University of Medicine of Padova, Padova, Italy

8. Department of Haematology University College Dublin, Dublin, Ireland

Publisher

Wiley

Subject

Cell Biology,Histology

Link

https://www.tandfonline.com/doi/pdf/10.3402/jev.v4.28414

Reference4 articles.

1. Binding of anticoagulant vitamin K-dependent protein S to platelet-derived microparticles

2. Role of Adhesion Molecules and Vascular Endothelium in the Pathogenesis of Sickle Cell Disease

3. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner

4. Activated protein C induces the release of microparticle-associated endothelial protein C receptor

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Routine hemostasis profile in steady state sickle cell disease adult patients compared to laboratory values, between phenotypes and during pregnancy: A retrospective, descriptive study;eJHaem;2024-08-20

2. A pharmacokinetic–pharmacodynamic analysis of l‐glutamine for the treatment of sickle cell disease: Implications for understanding the mechanism of action and evaluating response to therapy;British Journal of Haematology;2024-07-08

3. The clinical spectrum of HbSC sickle cell disease‐not a benign condition;British Journal of Haematology;2024-06-19

4. Multiplex Proteomics in the Identification of Potential Biomarkers of Very Severe Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease in Allogeneic Hematopoietic Cell Transplant Patients Treated with Defibrotide;Acta Haematologica;2024-02-08

5. Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism;Hemoglobin;2023-11-02